{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:05:28Z","timestamp":1785859528038,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.cej.0000197451.02604.25","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T04:01:16Z","timestamp":1141704076000},"page":"158-164","source":"Crossref","is-referenced-by-count":36,"title":["Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population"],"prefix":"10.1097","volume":"15","author":[{"given":"Salaheddin M.","family":"Mahmud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis R.","family":"B\u00e9gin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen G.","family":"Aprikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/jnci\/94.15.1168","article-title":"Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer","volume":"94","author":"Anderson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R2-9-20210128","first-page":"4629","article-title":"Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases","volume":"60","author":"Attiga","year":"2000","journal-title":"Cancer Res"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ijc.11466","article-title":"Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis","volume":"107","author":"Bruner","year":"2003","journal-title":"Int J Cancer"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/bjc.1991.481","article-title":"Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease","volume":"64","author":"Chaudry","year":"1991","journal-title":"Br J Cancer"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.2910570208","article-title":"Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors","volume":"57","author":"Chaudry","year":"1994","journal-title":"Int J Cancer"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(01)66840-X","article-title":"Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies","volume":"154","author":"Davidson","year":"1995","journal-title":"J Urol"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0895-4356(98)00152-8","article-title":"Adjusted odds ratios under nondifferential misclassification: application to prostate cancer","volume":"52","author":"Godley","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1015788502099","article-title":"Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US","volume":"13","author":"Habel","year":"2002","journal-title":"Cancer Causes Control"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J Biol Chem"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0022-5347(05)64277-2","article-title":"Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk","volume":"168","author":"Irani","year":"2002","journal-title":"J Urol"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","article-title":"Breast cancer and NSAID use: a meta-analysis","volume":"84","author":"Khuder","year":"2001","journal-title":"Br J Cancer"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.med.53.082901.104015","article-title":"Chemoprevention of aerodigestive tract cancers","volume":"53","author":"Kim","year":"2002","journal-title":"Annu Rev Med"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-4295(01)01255-9","article-title":"The role of cyclooxygenase-2 in prostate cancer","volume":"58","author":"Kirschenbaum","year":"2001","journal-title":"Urology"},{"key":"R17-9-20210128","first-page":"1108","article-title":"Aspirin use in relation to risk of prostate cancer","volume":"11","author":"Leitzmann","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0006-2952(99)00200-2","article-title":"Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines","volume":"58","author":"Lim","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"R19-9-20210128","first-page":"4245","article-title":"NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","article-title":"Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo","volume":"164","author":"Liu","year":"2000","journal-title":"J Urol"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1464-410x.2000.00867.x","article-title":"Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment","volume":"86","author":"Madaan","year":"2000","journal-title":"Br J Urol Int"},{"key":"R22-9-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bjc.6601416","article-title":"Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis","volume":"90","author":"Mahmud","year":"2004","journal-title":"Br J Cancer"},{"key":"R23-9-20210128","article-title":"AHFS drug information\u00ae 2004","author":"McEvoy","year":"2004"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X","article-title":"Non-steroidal anti-inflammatory drugs and prostate cancer progression","volume":"77","author":"Norrish","year":"1998","journal-title":"Int J Cancer"},{"key":"R25-9-20210128","first-page":"S100","article-title":"Non-steroidal anti-inflammtory drugs (NSAID) and prostate cancer (PC) risk: a population-based case-control study (abstract)","volume":"153","author":"Perron","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1532-5415.1999.tb01603.x","article-title":"Assessment and control for confounding by indication in observational studies","volume":"47","author":"Psaty","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.03.044","article-title":"COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer","volume":"31","author":"Sabichi","year":"2004","journal-title":"Semin Oncol"},{"key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0090-4295(01)01497-2","article-title":"Comparative evaluation of total PSA, free\/total PSA, and complexed PSA in prostate cancer detection","volume":"59","author":"Tanguay","year":"2002","journal-title":"Urology"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a117563","article-title":"Recall accuracy for prescription medications: self-report compared with database information","volume":"142","author":"West","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ije\/26.1.220","article-title":"Relationship between prevalence rate ratios and odds ratios in cross-sectional studies","volume":"26","author":"Zocchetti","year":"1997","journal-title":"Int J Epidemiol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00140068-200603000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:12:12Z","timestamp":1785856332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008469-200604000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.cej.0000197451.02604.25","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}